Report: Clinical trial opinions in rare disease
November 2020Results from our 2020 survey reveal drivers and barriers to clinical trial participation
As it became clear that 2020 would be a year like no other, we surveyed members of our rare disease community to learn more about their attitudes and opinions around clinical trials. We wanted to find out how willing people were to take part in trials, what they felt about decentralized trial designs and whether COVID-19 had an impact on their opinions.
Sign up for updates
If you’re an industry professional and would like to subscribe to updates from our research team, including our research projects and our Rare Opinion blog, fill in your details below and we’ll add you to our mailing list.